Skip to main content Accessibility Statement

Investors

At Tactile Medical, a fundamental value is to earn a fair profit and return value for our shareholders


--

Data Provided by Refinitiv. Minimum 15 minutes delayed.

Upcoming Events


MAR 12 2024 2:40 PM EDT

Tactile Systems Technology, Inc. at Oppenheimer 34th Annual Healthcare MedTech & Services Conference

MAR 12 2024 2:40 PM EDT

Recent News


  • Tactile Systems Technology, Inc. Reports Fourth Quarter and Full Year 2023 Financial Results; Introduces Full Year 2024 Outlook

    Full Year Revenue Increased 11% Year-Over-Year; Full Year Net Income Increased 260%; Full Year Adjusted EBITDA Increased 62% MINNEAPOLIS , Feb. 20, 2024 (GLOBE NEWSWIRE) -- Tactile Systems Technology, Inc. (“Tactile Medical”; the “Company”) (Nasdaq: TCMD), a medical technology company providing

    Read more
  • Tactile Medical to Participate in Upcoming Investor Conferences in February and March

    MINNEAPOLIS , Feb. 05, 2024 (GLOBE NEWSWIRE) -- Tactile Systems Technology, Inc. (“Tactile Medical”) (Nasdaq: TCMD), a medical technology company providing therapies for people with chronic disorders, today announced that management will participate in the following upcoming investor conferences:

    Read more
  • Tactile Medical to Release Fourth Quarter and Fiscal Year 2023 Financial Results on February 20, 2024

    MINNEAPOLIS , Jan. 29, 2024 (GLOBE NEWSWIRE) -- Tactile Systems Technology, Inc. (“Tactile Medical”; the “Company”) (Nasdaq: TCMD), a medical technology company providing therapies for people with chronic disorders, today announced that fourth quarter and fiscal year 2023 financial results will be

    Read more